Teva to acquire CoGenesys with a purchase price of $400 million cash
- Details
- Category: Financial
![Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd.](http://www.worldpharmanews.com/images/stories/logo/teva.gif)
Abbott Reports 16.1 Percent Sales Growth in Fourth Quarter
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
- Worldwide sales in the fourth quarter increased 16.1 percent to $7.2 billion, including a favorable 4.5 percent effect of exchange rates. For the full-year 2007, worldwide sales increased 15.3 percent to $25.9 billion, including a favorable 3.2 percent effect of exchange rates.
ANAVEX outlines corporate milestones, drug advancement plans for 2008
- Details
- Category: Business
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) reported that the company achieved significant development of its lead drug candidates and in the growth of its management and scientific teams during 2007. The company further disclosed key corporate objectives for 2008.
Roche invests 430 million Swiss francs at sites in Germany and Switzerland
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Novartis achieves record results in 2007 underscoring benefits of strategic healthcare portfolio
- Details
- Category: Novartis
![Novartis AG Novartis AG](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
First Head to Head Study Comparing CRESTOR and LIPITOR®
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
More Pharma News ...
- Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R)
- Pfizer Wins Key New York State Court Ruling on Celebrex
- Roche engages in four additional AIDS Technology Transfers
- Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
- Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
- Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate
- Expanded Labeling for MabCampath® in Europe